Literature DB >> 19657323

The biology of preeclampsia.

Keizo Kanasaki1, Raghu Kalluri.   

Abstract

Preeclampsia is a systemic disease that results from placental defects and occurs in about 5-8% of pregnancies worldwide. Preeclampsia is a disease of many theories, wherein investigators put forward their favorite mechanistic ideas, each with a causal appeal for the pathogenesis of preeclampsia. In reality, the patho-mechanism of preeclampsia remains largely unknown. Preeclampsia, as diagnosed in patients today, is likely a heterogeneous collection of disease entities that share some common features but also show important differences. Therefore, one single mechanism may never be found to explain all the variants of preeclampsia. Current research must focus on evaluating such diverse mechanisms, as well as the possible common effector pathways. Here, we provide a discussion of several possible mechanisms and putative theories proposed for preeclampsia, with particular emphasis on the recent discovery of a new genetic mouse model offering new opportunities to explore experimental therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657323      PMCID: PMC4313558          DOI: 10.1038/ki.2009.284

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  55 in total

1.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

Review 2.  Correlation of placental pathology with prenatal ultrasound findings.

Authors:  N J Sebire; W Sepulveda
Journal:  J Clin Pathol       Date:  2008-08-04       Impact factor: 3.411

3.  Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.

Authors:  S Helske; P Vuorela; O Carpén; C Hornig; H Weich; E Halmesmäki
Journal:  Mol Hum Reprod       Date:  2001-02       Impact factor: 4.025

4.  Successful treatment of long-lasting severe hypertension with captopril during a twin pregnancy.

Authors:  G Coen; P Cugini; G Gerlini; D Finistauri; G A Cinotti
Journal:  Nephron       Date:  1985       Impact factor: 2.847

5.  Captopril therapy in preeclampsia.

Authors:  B H Hurault de Ligny; J P Ryckelynck; P Mintz; G Levy; G Muller
Journal:  Nephron       Date:  1987       Impact factor: 2.847

6.  Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera.

Authors:  N O Lunell; L E Nylund; R Lewander; B Sarby
Journal:  Clin Exp Hypertens B       Date:  1982

7.  Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3)

Authors:  I Caniggia; H Mostachfi; J Winter; M Gassmann; S J Lye; M Kuliszewski; M Post
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

8.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

9.  Renin-aldosterone relationships in pregnancy-induced hypertension.

Authors:  M A Brown; V C Zammit; D A Mitar; J A Whitworth
Journal:  Am J Hypertens       Date:  1992-06       Impact factor: 2.689

10.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.

Authors:  J W Meekins; R Pijnenborg; M Hanssens; I R McFadyen; A van Asshe
Journal:  Br J Obstet Gynaecol       Date:  1994-08
View more
  50 in total

1.  Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta.

Authors:  Wen Wang; Lin Feng; Honghai Zhang; Stephanie Hachy; Seiro Satohisa; Louise C Laurent; Mana Parast; Jing Zheng; Dong-bao Chen
Journal:  J Clin Endocrinol Metab       Date:  2012-03-21       Impact factor: 5.958

2.  Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring.

Authors:  Eliel Kedar Sade; Tamar Wainstock; Erez Tsumi; Eyal Sheiner
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

3.  Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways.

Authors:  S Tsai; N E Hardison; A H James; A A Motsinger-Reif; S R Bischoff; B H Thames; J A Piedrahita
Journal:  Placenta       Date:  2010-12-22       Impact factor: 3.481

4.  Placental ischemia impairs middle cerebral artery myogenic responses in the pregnant rat.

Authors:  Michael J Ryan; Emily L Gilbert; Porter H Glover; Eric M George; C Warren Masterson; Gerald R McLemore; Babbette LaMarca; Joey P Granger; Heather A Drummond
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

5.  Maternal peripheral blood gene expression in early pregnancy and preeclampsia.

Authors:  Daniel A Enquobahrie; Chunfang Qiu; Seid Y Muhie; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2010-12-29

6.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

7.  Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia.

Authors:  JoonHo Lee; Roberto Romero; Zhong Dong; Deug-Chan Lee; Yi Dong; Pooja Mittal; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 8.  Current model systems for the study of preeclampsia.

Authors:  M L Martinez-Fierro; G P Hernández-Delgadillo; V Flores-Morales; E Cardenas-Vargas; M Mercado-Reyes; I P Rodriguez-Sanchez; I Delgado-Enciso; C E Galván-Tejada; J I Galván-Tejada; J M Celaya-Padilla; I Garza-Veloz
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-07

9.  Diagnosis and management of pre-eclampsia: an update.

Authors:  Judi A Turner
Journal:  Int J Womens Health       Date:  2010-09-30

10.  Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.

Authors:  Florian Herse; Babbette Lamarca; Carl A Hubel; Tea Kaartokallio; A Inkeri Lokki; Eeva Ekholm; Hannele Laivuori; Martin Gauster; Berthold Huppertz; Meryam Sugulle; Michael J Ryan; Sarah Novotny; Justin Brewer; Joon-Keun Park; Michael Kacik; Joachim Hoyer; Stefan Verlohren; Gerd Wallukat; Michael Rothe; Friedrich C Luft; Dominik N Muller; Wolf-Hagen Schunck; Anne C Staff; Ralf Dechend
Journal:  Circulation       Date:  2012-11-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.